These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29663340)

  • 1. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy.
    Erstad DJ; Fuchs BC; Tanabe KK
    Cancer; 2018 Aug; 124(15):3084-3104. PubMed ID: 29663340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint therapy in liver cancer.
    Xu F; Jin T; Zhu Y; Dai C
    J Exp Clin Cancer Res; 2018 May; 37(1):110. PubMed ID: 29843754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma.
    Zhang Q; Qiao L; Liao J; Liu Q; Liu P; Liu L
    J Cell Mol Med; 2021 Apr; 25(8):3772-3784. PubMed ID: 33616276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma.
    Zhao J; Liu Z; Yang K; Shen S; Peng J
    Front Immunol; 2024; 15():1333923. PubMed ID: 38736884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating transcriptomes and somatic mutations to identify RNA methylation regulators as a prognostic marker in hepatocellular carcinoma.
    Yan Y; Luo YH; Zheng DF; Mu T; Wu ZJ
    Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):34-45. PubMed ID: 32563589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma.
    Shi R; Zhao H; Zhao S; Yuan H
    Aging (Albany NY); 2022 Jun; 14(12):5271-5291. PubMed ID: 35771147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients.
    He G; Fu S; Li Y; Li T; Mei P; Feng L; Cai L; Cheng Y; Zhou C; Tang Y; Huang W; Liu H; Cen B; Pan M; Gao Y
    Aging (Albany NY); 2020 Nov; 12(21):21544-21558. PubMed ID: 33177245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery.
    Zhang S; Deshpande A; Verma BK; Wang H; Mi H; Yuan L; Ho WJ; Jaffee EM; Zhu Q; Anders RA; Yarchoan M; Kagohara LT; Fertig EJ; Popel AS
    Cancer Res; 2024 Aug; 84(16):2734-2748. PubMed ID: 38861365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.
    Wang Z; Zhang S
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications.
    Huang X; Yang C; Wang J; Sun T; Xiong H
    Aging (Albany NY); 2020 Mar; 12(6):4970-4995. PubMed ID: 32201399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma.
    Chen J; Gingold JA; Su X
    Trends Mol Med; 2019 Nov; 25(11):1010-1023. PubMed ID: 31353124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
    Cai J; Zhou M; Xu J
    World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.